InterHealth’s UC-II ‘safe and effective’ for supporting joint health
A poster presenting results of the 17-week randomized, double-blind, placebo-controlled study with 55 participants took first place at the 2013 Scripps Natural Supplement Conference earlier this year. The research abstract is published in the Journal of Alternative and Complementary Medicine.
Principal researcher, Jay Udani, MD, CEO of Medicus Research, reported: “Supplementation with UC-II for seventeen weeks was well-tolerated and more effective than placebo in supporting joint comfort, flexibility and mobility.”
The study used healthy participants and none met the American College of Rheumatology criteria for osteoarthritis.
The study supports 2009 findings published in International Journal of Medical Sciences (Vol. 6, pp. 312-321), said InterHealth.
“The research results from this healthy population study not only represents great clinical findings in terms of UC-II and joint health, but represent a great marketing opportunity for dietary supplement manufacturers as well,” said Jay Martin, VP of sales and marketing at InterHealth.
Source: The Journal of Alternative and Complimentary Medicine
Volume 19, Number 6, pp. A1–A10, doi: 10.1089/acm.2013.1501
“UC-II(R) for Joint Health: A Randomized, Double-Blind, Placebo-Controlled, Adaptive Design, Pilot Study”
Authors: J. Udani
